3rd Quarter - Report

AKIN GUMP STRAUSS HAUER & FELD for GILEAD SCIENCES INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
$20,000
Expenses
—

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
3rd Quarter - Report (this page) Oct 20, 2019 $20,000 Replaced
3rd Quarter - Amendment Oct 21, 2019 $60,000 Yes

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.

LobbyistCovered position, as disclosed
GORDON HUNTER BATES —
SMITH W DAVIS —
VIC FAZIO —
STEPHEN KHO —
CARYN DYSON LESTER —
JUSTIN MCCARTHY —
ED PAGANO —
BRIAN ARTHUR POMPER —

Contacted: SENATE; U.S. Trade Representative (USTR); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; State, Dept of (DOS); Commerce, Dept of (DOC)

Bills named: S. 3506 (116th)

Health Issues HCR

International trade and protection of intellectual property, HIV policy issue, Hepatitis C (HCV) policy issues, the CREATES Act (S.3506); PEPFAR; public health initiatives around opioids and infectious diseases.

Contacted: State, Dept of (DOS); U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Commerce, Dept of (DOC); SENATE; Health & Human Services, Dept of (HHS)

Bills named: S. 3506 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.